$OKLO

Bealmear Richard Craig sold $638K of OKLO

Bealmear Richard Craig (Chief Financial Officer) sold 16,452 shares of Oklo Inc. (OKLO) at $38.80 ($0.64M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bealmear Richard Craig
Published Aug 5, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
high confidence
Mentioned
$OKLO
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

This provides a concrete datapoint on insider selling activity but does not include any new company-specific business development, guidance, or regulatory action.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and lack of new fundamentals make it a low-signal catalyst.

03

What to watch

The filing does not state reasons for sale, and 10b5-1 plans can be executed regardless of company outlook; without accompanying news, trading impact should be treated as marginal.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-05 after-hours; transaction dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for Oklo Inc., reported by its CFO.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

Oklo CFO Bealmear Richard Craig filed a Form 4 selling 16,452 shares at $38.80 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale; any impact would be sentiment-driven and likely short-lived.

Evidence & confidence

Form 4 insider sales on 10b5-1 plans are typically expected and not the same as discretionary selling; the article provides no new operational, financial, or regulatory catalyst.

Market effects

No sector-level implications disclosed; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, unusually large or clustered insider sales can still be read as management de-risking, potentially pressuring sentiment temporarily.

Key entities

  • Oklo Inc.

    Subject of the Form 4 insider sale disclosure.

  • Bealmear Richard Craig

    Oklo CFO who sold shares under a pre-arranged 10b5-1 plan.

Related articles

$OKLOMed

Oklo’s Groves Research Reactor Achieves First Criticality

Oklo (NYSE: OKLO) said its Groves Isotope Test Reactor reached first criticality on private land, supported by DOE Reactor Pilot Program authorization. Los Alamos’ ZiaCore microreactor also achieved zero-power criticality. ARC Clean Technology (ARC) outlined plans for ARC-100 at INL and a term sheet for Turkey. Holtec, Entergy and Hyundai will evaluate SMR-300 projects in Gulf states.

$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.

$OKLOMed

Oklo Stock Attempts a Turnaround, but Technical Barriers Remain as It Releases Q2 2026 Financial Results

Oklo reported Q2 2026 revenue of $1.2 million, above analysts’ ~$83,800 estimate, but posted a $0.28 per-share loss versus a ~$0.16 consensus. Net loss widened to $48.5 million from $24.7 million a year earlier. The company ended the quarter with about $3 billion in cash and marketable securities and said its Groves Isotope Test Reactor achieved first criticality.

$OKLOMedAI 8/10

Oklo reports $1.21M Q2 revenue, $1.6B cash as Aurora milestones advance

Oklo Inc. (NYSE: OKLO) reported Q2 2026 revenue of $1.21M versus a $126,250 analyst estimate and an EPS loss of $(0.28) versus an estimated $(0.16). The company said it ended the quarter with $1.6B cash and expects 2026 operating cash flow of $120M to $150M and capex of $400M to $500M. It also advanced Aurora regulatory steps and said its Groves reactor reached first criticality.